Role of Mitochondrial Oxidative Stress in Sepsis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Mitochondria are considered the power house of the cell and are an essential part of the cellular infrastructure, serving as the primary site for adenosine triphosphate production via oxidative phosphorylation. These organelles also release reactive oxygen species (ROS), which are normal byproducts of metabolism at physiological levels; however, overproduction of ROS under pathophysiological conditions is considered part of a disease process, as in sepsis. The inflammatory response inherent in sepsis initiates changes in normal mitochondrial functions that may result in organ damage. There is a complex system of interacting antioxidant defenses that normally function to combat oxidative stress and prevent damage to the mitochondria. It is widely accepted that oxidative stress-mediated injury plays an important role in the development of organ failure; however, conclusive evidence of any beneficial effect of systemic antioxidant supplementation in patients with sepsis and organ dysfunction is lacking. Nevertheless, it has been suggested that antioxidant therapy delivered specifically to the mitochondria may be useful.
Abstract
Mitochondria are considered the power house of the cell and are an essential part of the cellular infrastructure, serving as the primary site for adenosine triphosphate production via oxidative phosphorylation. These organelles also release reactive oxygen species (ROS), which are normal byproducts of metabolism at physiological levels; however, overproduction of ROS under pathophysiological conditions is considered part of a disease process, as in sepsis. The inflammatory response inherent in sepsis initiates changes in normal mitochondrial functions that may result in organ damage. There is a complex system of interacting antioxidant defenses that normally function to combat oxidative stress and prevent damage to the mitochondria. It is widely accepted that oxidative stress-mediated injury plays an important role in the development of organ failure; however, conclusive evidence of any beneficial effect of systemic antioxidant supplementation in patients with sepsis and organ dysfunction is lacking. Nevertheless, it has been suggested that antioxidant therapy delivered specifically to the mitochondria may be useful.
참고문헌 (51)
- Vincent JL, "Sepsis in European intensive care units: results of the SOAP study", Crit Care Med, 34, pp.344~353 (2006)[DOI]
- Angus DC, "Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care", Crit Care Med, 29, pp.1303~1310 (2001)[DOI]
- De Kock I, "Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy", Acta Clin Belg, 65, pp.323~329 (2010)[DOI]
- Mantzarlis K, "Role of oxidative stress and mitochondrial dysfunction in sepsis and potential therapies", Oxid Med Cell Longev, 2017, pp.5985209~ (2017)
- Fang X, "Role of mitochondrial dysfunction in the pathogenesis of septic cardiomyopathy", Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 30, pp.189~192 (2018)
- Hotchkiss RS, "The pathophysiology and treatment of sepsis", N Engl J Med, 348, pp.138~150 (2003)[DOI]
- Abraham E, "Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial", JAMA, 273, pp.934~941 (1995)[DOI]
- Sprung CL, "Hydrocortisone therapy for patients with septic shock", N Engl J Med, 358, pp.111~124 (2008)[DOI]
- Fisher CJ Jr, "Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, doubleblind, placebo-controlled trial", JAMA, 271, pp.1836~1843 (1994)[DOI]
- Bone RC, "A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock", N Engl J Med, 317, pp.653~658 (1987)[DOI]
- Hotchkiss RS, "Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction", Crit Care Med, 27, pp.1230~1251 (1999)[DOI]
- Chance B, "Hydroperoxide metabolism in mammalian organs", Physiol Rev, 59, pp.527~605 (1979)[DOI]
- Brealey D, "Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure", Am J Physiol Regul Integr Comp Physiol, 286, pp.491~497 (2004)[DOI]
- Andrades M, "Oxidative parameters differences during non-lethal and lethal sepsis development", J Surg Res, 125, pp.68~72 (2005)[DOI]
- Sener G, "Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis", Int Immunopharmacol, 5, pp.1387~1396 (2005)[DOI]
- Sener G, "Melatonin protects against oxidative organ injury in a rat model of sepsis", Surg Today, 35, pp.52~59 (2005)
- Prauchner CA, "Effects of diphenyl diselenide on oxidative stress induced by sepsis in rats", Pathol Res Pract, 207, pp.554~558 (2011)[DOI]
- Flohe L, "Glutathione peroxidase: a selenoenzyme", FEBS Lett, 32, pp.132~134 (1973)[DOI]
- Tapiero H, "The antioxidant role of selenium and seleno-compounds", Biomed Pharmacother, 57, pp.134~144 (2003)[DOI]
- Rederstorff M, "Understanding the importance of selenium and selenoproteins in muscle function", Cell Mol Life Sci, 63, pp.52~59 (2006)[DOI]
- Boekstegers P, "Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: comparison to limited infection and cardiogenic shock", Infection, 19, pp.317~323 (1991)[DOI]
- Sair M, "Tissue oxygenation and perfusion in patients with systemic sepsis", Crit Care Med, 29, pp.1343~1349 (2001)[DOI]
- Crouser ED, "Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome", Mitochondrion, 4, pp.729~741 (2004)[DOI]
- Fink MP, "Cytopathic hypoxia: mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis", Crit Care Clin, 17, pp.219~237 (2001)[DOI]
- Brealey D, "Association between mitochondrial dysfunction and severity and outcome of septic shock", Lancet, 360, pp.219~223 (2002)[DOI]
- Carre JE, "Survival in critical illness is associated with early activation of mitochondrial biogenesis", Am J Respir Crit Care Med, 182, pp.745~751 (2010)[DOI]
- Kozlov AV, "Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?", Ann Intensive Care, 1, pp.41~ (2011)[DOI]
- Kumar S, "Evaluation of oxidative stress and antioxidant status: correlation with the severity of sepsis", Scand J Immunol, 87, pp.e12653~ (2018)[DOI]
- Macarthur H, "Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines", Crit Care Med, 31, pp.237~245 (2003)[DOI]
- Chen GD, "Insulin alleviates mitochondrial oxidative stress involving upregulation of superoxide dismutase 2 and uncoupling protein 2 in septic acute kidney injury", Exp Ther Med, 15, pp.3967~3975 (2018)
- Murphy MP, "Targeting antioxidants to mitochondria by conjugation to lipophilic cations", Annu Rev Pharmacol Toxicol, 47, pp.629~656 (2007)[DOI]
- Ross MF, "Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology", Biochemistry (Mosc), 70, pp.222~230 (2005)[DOI]
- Kelso GF, "Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties", J Biol Chem, 276, pp.4588~4596 (2001)[DOI]
- Dhanasekaran A, "Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis", J Biol Chem, 279, pp.37575~37587 (2004)[DOI]
- Lowes DA, "The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis", Free Radic Biol Med, 45, pp.1559~1565 (2008)[DOI]
- Escribano-Lopez I, "The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients", Redox Biol, 10, pp.200~205 (2016)[DOI]
- Supinski GS, "MitoQ administration prevents endotoxin-induced cardiac dysfunction", Am J Physiol Regul Integr Comp Physiol, 297, pp.1095~1102 (2009)[DOI]
- Snow BJ, "A double-blind, placebocontrolled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease", Mov Disord, 25, pp.1670~1674 (2010)[DOI]
- Filipovska A, "Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic: insights into the interaction of ebselen with mitochondria", J Biol Chem, 280, pp.24113~24126 (2005)[DOI]
- McDonald MC, "Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion", Free Radic Biol Med, 27, pp.493~503 (1999)[DOI]
- Mota-Filipe H, "A membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock", Shock, 12, pp.255~261 (1999)[DOI]
- Fink MP, "Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted antioxidants", Crit Care Med, 35(9 Suppl), pp.S461~S467 (2007)[DOI]
- Macias CA, "Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shock", Ann Surg, 245, pp.305~314 (2007)[DOI]
- Patil NK, "Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury", Am J Physiol Renal Physiol, 306, pp.F734~F743 (2014)[DOI]
- Escames G, "Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice", J Pineal Res, 40, pp.71~78 (2006)[DOI]
- Escames G, "Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice", FEBS J, 274, pp.2135~2147 (2007)[DOI]
- Wu JY, "Therapeutic effects of melatonin on peritonitisinduced septic shock with multiple organ dysfunction syndrome in rats", J Pineal Res, 45, pp.106~116 (2008)[DOI]
- Gitto E, "Effects of melatonin treatment in septic newborns", Pediatr Res, 50, pp.756~760 (2001)[DOI]
- Galley HF, "Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis", J Pineal Res, 56, pp.427~438 (2014)[DOI]
- Packer L, "Alpha-lipoic acid as a biological antioxidant", Free Radic Biol Med, 19, pp.227~250 (1995)[DOI]
- Petronilho F, "Alpha-lipoic acid attenuates oxidative damage in organs after sepsis", Inflammation, 39, pp.357~365 (2016)[DOI]
